During the past decade, Ambulatori Medicina della Sessualità e Andrologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ambulatori Medicina della Sessualità e Andrologia" are "Hypogonadism" (2 trials), "Prostatic Hyperplasia" (2 trials), "Contraceptive Usage" (1 trials), "Erectile Dysfunction" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Ambulatori Medicina della Sessualità e Andrologia" in a lesser frequency.

Most popular intervention types in "Ambulatori Medicina della Sessualità e Andrologia" are "Drug" (3 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "CBST" (1 trials), "Combined Estrogen-Progestin Oral Contraceptives" (1 trials), "Placebo" (1 trials), "Testosterone gel 2%" (1 trials) and "Vardenafil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ambulatori Medicina della Sessualità e Andrologia" are 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ambulatori Medicina della Sessualità e Andrologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ambulatori Medicina della Sessualità e Andrologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ambulatori Medicina della Sessualità e Andrologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".